Updated:
Big Health
Big Health sells clinically validated digital CBT treatments for insomnia and anxiety to health systems, co-founded by Peter Hames and Dr. Colin Espie.
Big Health
Proven digital treatments and programs that deliver effective, accessible care for the most common mental health conditions. Get started today.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Principals
Yael Berman
CEO
Peter Hames
Co-founder
Colin Espie
Co-founder
Sector focus
Frequently asked questions
How does Big Health's clinical validation process determine which products it commercializes?
Big Health only brings a digital treatment to market after it demonstrates efficacy through peer-reviewed research and randomized controlled trials. This mirrors the clinical-trial standard of a pharmaceutical rather than the beta-launch model of a consumer wellness app, ensuring its products can satisfy formulary review by health system pharmacy and therapeutics committees.
What conditions do Big Health's existing digital therapeutics treat?
The firm's two commercially available programs are Sleepio, a digital cognitive behavioral therapy for insomnia, and Daylight, which targets generalized anxiety. A youth mental health product is in development, though no launch date has been announced.
Who runs the company now, and how did the CEO transition work?
Yael Berman was appointed CEO in 2025. Co-founder Peter Hames, who previously held the role, remains with the company. The transition marks a shift from founder-led product development toward operational scaling as the company signs contracts with major health systems.
Does Big Health derive revenue from direct-to-consumer sales or enterprise contracts?
Big Health focuses on enterprise and health-system contracts rather than consumer subscriptions. Its commercial engine is driven by the adoption of new CPT billing codes that allow US payers and providers to reimburse prescribed digital therapeutics, positioning it as a covered clinical benefit.
How does Big Health's regulatory and reimbursement posture differ from consumer mental health apps?
Unlike general wellness or meditation apps, Big Health's treatments are prescribed through clinical workflows and reimbursed via payer codes. The company's products carry the clinical-evidence standard required for inclusion in a health plan's medical benefit, not a lifestyle spending account or employee perk program.
What geographies does Big Health serve?
The company operates primarily in the United States and the United Kingdom, targeting English-language markets where its clinical evidence base is established and where digital-therapeutic billing codes have gained regulatory traction.
Is Big Health backed by venture capital or is it a subsidiary of a larger health system?
Big Health is a standalone venture-backed company. In 2025 it closed a funding round explicitly tied to scaling adoption of evidence-based digital care as new billing codes accelerate health-system purchasing, as described on the firm's website.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: